Founders
 |
 |
TAREK SHERIF
Co-Founder, Chairman & Chief Executive Officer
One of the founders of Medidata Solutions, Tarek has served as chief executive officer since 2001. Tarek has effectively orchestrated the evolution of the company to become one of the industry leaders in clinical technology and services, now relied upon by leading biopharmaceutical companies worldwide. Throughout Tarek's tenure, Medidata Solutions has experienced significant growth in order to support ongoing and new clinical trials in more than 80 countries. In his role as Chairman and CEO, Tarek is involved in business development, as well as general and strategic management including budgets, sales and marketing, product development, finance, human resources, and customer and partner relations.
Tarek brings to Medidata Solutions more than 16 years of broad-based financial and managerial experience. He has founded and managed a variety of technology and service driven businesses, focusing on strategic initiatives, financial management and analysis. Prior to forming Medidata Solutions, Tarek was the managing member of a partnership focused on public and private investments in technology and life science companies, where he managed both long and short equity hedge funds.
Previously, he co-managed a privately held equity fund specializing in publicly traded technology companies, including those in the healthcare and information technology fields. He has also served as assistant vice president of corporate finance at General Electric Capital Corporation, and mergers and acquisitions analyst at Brown Brothers Harriman & Company.
Tarek received his B.A. in Economics from Yale University in 1984. Following a career on Wall Street, Tarek attended Columbia Business School where he earned a degree in business administration and finance and graduated first in a class of 650 students in 1991.
 |
|
GLEN DE VRIES
Co-Founder & President
Glen is one of the founders of Medidata Solutions and the original architect of the Medidata Rave® electronic data capture and clinical data management system. Since the company's inception, Glen has been responsible for driving Medidata's technology vision, building the company's critical sponsor and partner relationships, and helping to forge a new eClinical reality for the biopharmaceutical industry. He has also been instrumental in drawing top talent from the clinical research community and enterprise software and IT industries to bring a range of expertise to the Medidata team.
Prior to his work with Medidata Solutions, Glen’s pioneering efforts in online physician/patient relationships were featured by The New York Times and drew the attention of the Office of Health and Human Services. He has over 10 years of experience in medical software development, including Electronic Health Records and consumer-targeted products. As president of OceanTek, a web development firm focused on applications for the healthcare industry, he was the chief consultant for a Fortune 500 global e-commerce project, and was the author of web security components currently in use by thousands of web sites and corporate intranets.
Glen has studied probabilistic algorithms at the Courant Institute of Mathematics (New York University) and received his B.S. in molecular biology and genetics from Carnegie Mellon University. His subsequent work at Columbia University focused on both research science and medical informatics, working on a blood assay for the detection of micro-metastases in prostate cancer patients, and creating a paperless clinical data management system. His peer-reviewed papers have been published in Cancer, the Journal of Urology, Molecular Diagnostics, Urology, and Urologic Clinics of North America.
Glen has been a featured presenter at multiple Drug Information Association (DIA) meetings in U.S., as well as DIA Japan, SCDM, Bio-IT World, BIOPHEX, Partnerships with CROs, the National Medical Association Annual Meeting, and American Urological Association Annual Meetings.